Skip to main content

Enter your search

Results will be displayed to the left.

Pelvic Binder Application

Question# 1000

Hello,
My question is about guidance on pelvic binders (PBs). I had a call recently where a motor cyclist low sided his bike and skidded into a ditch at highway speed. He had good recollection with no LOC and was walking on scene prior to our arrival. His initial vital signs were BP high 80s systolic but a MAP of 75 and HR in the high 70s with normal resps and GCS 15. I interpreted the BP as a positional thing and sure enough when he sat up his BP was 130. I did a gentle pelvic assessment with no positive findings and based on that and him walking elected not to use a PB. My supervisor and other medics had a discussion about this and the consensus was that a PB should be applied based on mechanism only and not any pt assessment findings. Another organization I work for is pulling back on the liberal use of PB given research coming out. I can’t find specific RPPEO guidance on PBs and was hoping to get more direct guidance. Thanks
James

Answer:

Current evidence does not support the routine application of a pelvic binder based on mechanism of injury alone. Rather, pelvic binder application should be guided by the overall clinical presentation, particularly the presence of suspected pelvic injury in conjunction with hemodynamic instability.

The American College of Surgeons (ACS) recommends placement of a pelvic binder as part of the resuscitation of patients who are hemodynamically unstable with a suspected pelvic fracture. The guideline also emphasizes the importance of a rapid assessment to identify other potential sources of hemorrhage rather than attributing hypotension solely to pelvic injury.

Similarly, the 2025 National Association of EMS Physicians (NAEMSP) Position Statement notes that the routine prehospital use of pelvic circumferential compression devices (PCCDs) should be reconsidered, citing insufficient evidence that they reduce hemorrhage or mortality and acknowledging the potential for device-related complications. The statement also notes that manual pelvic stability testing has poor diagnostic accuracy and may cause harm; therefore, a negative examination should not be used in isolation to exclude pelvic injury.

Evidence also suggests that mechanism alone is a poor predictor of patients who will ultimately require pelvic intervention. Studies have demonstrated that a relatively small proportion of patients transported with pelvic binders are subsequently found to have clinically significant pelvic fractures requiring intervention, supporting a more selective approach to binder application.

Although pelvic binders are generally considered low risk when applied appropriately, unnecessary use is not without potential consequences. Reported complications include skin and soft tissue injury, pressure-related complications with prolonged application, potential worsening of certain fracture patterns, and the possibility of delaying recognition of other sources of hemorrhage.

In the scenario described, the patient was ambulatory, had a GCS of 15, demonstrated normalization of blood pressure with repositioning, and had no persistent signs of hemodynamic instability. Based on the available information, the decision not to apply a pelvic binder was reasonable and is consistent with current evidence supporting selective rather than mechanism-based application. Ongoing reassessment of the patient's hemodynamic status and clinical condition throughout transport remains essential, as occult bleeding and delayed deterioration may still occur.

Published

24 July 2026

ALSPCS Version

5.4

Views

12

Please reference the MOST RECENT ALS PCS for updates and changes to these directives.